Skip to main content
Top
Published in: Calcified Tissue International 1/2011

01-01-2011

Osteoclasts Lacking Rac2 Have Defective Chemotaxis and Resorptive Activity

Authors: Takashi Itokowa, Mei-ling Zhu, Nancy Troiano, Jessica Bian, Tustomu Kawano, Karl Insogna

Published in: Calcified Tissue International | Issue 1/2011

Login to get access

Abstract

The role of the small Rho GTPase Rac2 in mature osteoclasts has not been extensively studied. Rac2−/− mice are of normal size and have normal tooth eruption. However, femoral cortical thickness was significantly greater in Rac2−/− compared to wild-type mice, while percent cortical porosity was lower. As assessed by histomorphometry, trabecular bone mass was significantly higher in male Rac2−/− than wild-type animals, although trabecular bone mass was similar when data from male and female animals were combined. There were no significant differences in the number of osteoblasts per bone surface; however, the number of osteoclasts per total bone area tended to be higher in Rac2−/− mice and was significantly higher in male Rac2−/− mice. In the aggregate, these data suggested a defect in osteoclast function and, consistent with that, rates of bone resorption were significantly reduced in Rac2−/− osteoclasts. In addition, Rac2−/− osteoclasts had a significantly delayed spreading response to treatment with CSF1 for 15 min. Phalloidin staining showed areas of abnormal actin accumulation and impaired actin ring formation in Rac2−/− osteoclasts. Finally, Rac2−/− osteoclasts showed a marked defect in chemotaxis toward a point source of CSF1, with a dramatic reduction in migratory rate. Together, these findings indicate an important role for Rac2 in mature osteoclasts.
Literature
1.
go back to reference Roodman GD (1996) Advances in bone biology: the osteoclast. Endocr Rev 17:308–332PubMed Roodman GD (1996) Advances in bone biology: the osteoclast. Endocr Rev 17:308–332PubMed
2.
go back to reference Lea CK, Sarma U, Flanagan AM (1999) Macrophage colony stimulating-factor transcripts are differentially regulated in rat bone-marrow by gender hormones. Endocrinology 140:273–279CrossRefPubMed Lea CK, Sarma U, Flanagan AM (1999) Macrophage colony stimulating-factor transcripts are differentially regulated in rat bone-marrow by gender hormones. Endocrinology 140:273–279CrossRefPubMed
3.
go back to reference Srivastava S, Weitzmann MN, Kimble RB, Rizzo M, Zahner M, Milbrandt J, Ross FP, Pacifici R (1998) Estrogen blocks M-CSF gene expression and osteoclast formation by regulating phosphorylation of Egr-1 and its interaction with Sp-1. J Clin Invest 102:1850–1859CrossRefPubMed Srivastava S, Weitzmann MN, Kimble RB, Rizzo M, Zahner M, Milbrandt J, Ross FP, Pacifici R (1998) Estrogen blocks M-CSF gene expression and osteoclast formation by regulating phosphorylation of Egr-1 and its interaction with Sp-1. J Clin Invest 102:1850–1859CrossRefPubMed
4.
go back to reference Cenci S, Weitzmann MN, Gentile MA, Aisa MC, Pacifici R (2000) M-CSF neutralization and egr-1 deficiency prevent ovariectomy-induced bone loss. J Clin Invest 105:1279–1287CrossRefPubMed Cenci S, Weitzmann MN, Gentile MA, Aisa MC, Pacifici R (2000) M-CSF neutralization and egr-1 deficiency prevent ovariectomy-induced bone loss. J Clin Invest 105:1279–1287CrossRefPubMed
5.
go back to reference Weir EC, Horowitz MC, Baron R, Centrella M, Kacinski BM, Insogna KL (1993) Macrophage colony-stimulating factor release and receptor expression in bone cells. J Bone Miner Res 8:1507–1518CrossRefPubMed Weir EC, Horowitz MC, Baron R, Centrella M, Kacinski BM, Insogna KL (1993) Macrophage colony-stimulating factor release and receptor expression in bone cells. J Bone Miner Res 8:1507–1518CrossRefPubMed
6.
go back to reference Owens J, Chambers TJ (1993) Macrophage colony-stimulating factor (M-CSF) induces migration in osteoclasts in vitro. Biochem Biophys Res Commun 195:1401–1407CrossRefPubMed Owens J, Chambers TJ (1993) Macrophage colony-stimulating factor (M-CSF) induces migration in osteoclasts in vitro. Biochem Biophys Res Commun 195:1401–1407CrossRefPubMed
7.
go back to reference Fuller K, Owens JM, Jagger CJ, Wilson A, Moss R, Chambers TJ (1993) Macrophage colony-stimulating factor stimulates survival and chemotactic behavior in isolated osteoclasts. J Exp Med 178:1733–1744CrossRefPubMed Fuller K, Owens JM, Jagger CJ, Wilson A, Moss R, Chambers TJ (1993) Macrophage colony-stimulating factor stimulates survival and chemotactic behavior in isolated osteoclasts. J Exp Med 178:1733–1744CrossRefPubMed
8.
go back to reference Grey A, Chen Y, Paliwal I, Carlberg K, Insogna K (2000) Evidence for a functional association between phosphatidylinositol 3-kinase and c-src in the spreading response of osteoclasts to colony-stimulating factor-1. Endocrinology 141:2129–2138CrossRefPubMed Grey A, Chen Y, Paliwal I, Carlberg K, Insogna K (2000) Evidence for a functional association between phosphatidylinositol 3-kinase and c-src in the spreading response of osteoclasts to colony-stimulating factor-1. Endocrinology 141:2129–2138CrossRefPubMed
9.
go back to reference Sakai H, Chen Y, Itokawa T, Yu KP, Zhu ML, Insogna K (2006) Activated c-Fms recruits Vav and Rac during CSF-1-induced cytoskeletal remodeling and spreading in osteoclasts. Bone 39:1290–1301CrossRefPubMed Sakai H, Chen Y, Itokawa T, Yu KP, Zhu ML, Insogna K (2006) Activated c-Fms recruits Vav and Rac during CSF-1-induced cytoskeletal remodeling and spreading in osteoclasts. Bone 39:1290–1301CrossRefPubMed
12.
go back to reference Allen WE, Jones GE, Pollard JW, Ridley AJ (1997) Rho, Rac and Cdc42 regulate actin organization and cell adhesion in macrophages. J Cell Sci 110(Pt 6):707–720PubMed Allen WE, Jones GE, Pollard JW, Ridley AJ (1997) Rho, Rac and Cdc42 regulate actin organization and cell adhesion in macrophages. J Cell Sci 110(Pt 6):707–720PubMed
13.
go back to reference Faccio R, Teitelbaum SL, Fujikawa K, Chappel J, Zallone A, Tybulewicz VL, Ross FP, Swat W (2005) Vav3 regulates osteoclast function and bone mass. Nat Med 11:284–290CrossRefPubMed Faccio R, Teitelbaum SL, Fujikawa K, Chappel J, Zallone A, Tybulewicz VL, Ross FP, Swat W (2005) Vav3 regulates osteoclast function and bone mass. Nat Med 11:284–290CrossRefPubMed
14.
go back to reference Fukuda A, Hikita A, Wakeyama H, Akiyama T, Oda H, Nakamura K, Tanaka S (2005) Regulation of osteoclast apoptosis and motility by small GTPase binding protein Rac1. J Bone Miner Res 20:2245–2253CrossRefPubMed Fukuda A, Hikita A, Wakeyama H, Akiyama T, Oda H, Nakamura K, Tanaka S (2005) Regulation of osteoclast apoptosis and motility by small GTPase binding protein Rac1. J Bone Miner Res 20:2245–2253CrossRefPubMed
15.
go back to reference Wang Y, Lebowitz D, Sun C, Thang H, Grynpas MD, Glogauer M (2008) Identifying the relative contributions of rac1 and rac2 to osteoclastogenesis. J Bone Miner Res 23:260–270CrossRefPubMed Wang Y, Lebowitz D, Sun C, Thang H, Grynpas MD, Glogauer M (2008) Identifying the relative contributions of rac1 and rac2 to osteoclastogenesis. J Bone Miner Res 23:260–270CrossRefPubMed
16.
go back to reference Roberts AW, Kim C, Zhen L, Lowe JB, Kapur R, Petryniak B, Spaetti A, Pollock JD, Borneo JB, Bradford GB, Atkinson SJ, Dinauer MC, Williams DA (1999) Deficiency of the hematopoietic cell–specific Rho family GTPase Rac2 is characterized by abnormalities in neutrophil function and host defense. Immunity 10:183–196CrossRefPubMed Roberts AW, Kim C, Zhen L, Lowe JB, Kapur R, Petryniak B, Spaetti A, Pollock JD, Borneo JB, Bradford GB, Atkinson SJ, Dinauer MC, Williams DA (1999) Deficiency of the hematopoietic cell–specific Rho family GTPase Rac2 is characterized by abnormalities in neutrophil function and host defense. Immunity 10:183–196CrossRefPubMed
17.
go back to reference Knopp E, Troiano N, Bouxsein M, Sun BH, Lostritto K, Gundberg C, Dziura J, Insogna K (2005) The effect of aging on the skeletal response to intermittent treatment with parathyroid hormone. Endocrinology 146:1983–1990CrossRefPubMed Knopp E, Troiano N, Bouxsein M, Sun BH, Lostritto K, Gundberg C, Dziura J, Insogna K (2005) The effect of aging on the skeletal response to intermittent treatment with parathyroid hormone. Endocrinology 146:1983–1990CrossRefPubMed
18.
go back to reference Insogna KL, Stewart AF, Vignery AM, Weir EC, Namnum PA, Baron RE, Kirkwood JM, Deftos LM, Broadus AE (1984) Biochemical and histomorphometric characterization of a rat model for humoral hypercalcemia of malignancy. Endocrinology 114:888–896CrossRefPubMed Insogna KL, Stewart AF, Vignery AM, Weir EC, Namnum PA, Baron RE, Kirkwood JM, Deftos LM, Broadus AE (1984) Biochemical and histomorphometric characterization of a rat model for humoral hypercalcemia of malignancy. Endocrinology 114:888–896CrossRefPubMed
19.
go back to reference Lee S-K, Kadono Y, Okada F, Claire Jacquin C, Koczon-Jaremko B, Gloria Gronowicz G, Adams DJ, Aguila HL, Choi Y, Lorenzo JA (2006) T lymphocyte deficient mice lose trabecular bone mass with ovariectomy. J Bone Miner Res 21:1704–1712CrossRefPubMed Lee S-K, Kadono Y, Okada F, Claire Jacquin C, Koczon-Jaremko B, Gloria Gronowicz G, Adams DJ, Aguila HL, Choi Y, Lorenzo JA (2006) T lymphocyte deficient mice lose trabecular bone mass with ovariectomy. J Bone Miner Res 21:1704–1712CrossRefPubMed
20.
go back to reference Harrison JR, Huang YF, Wilson KA, Kelly PL, Adams DJ, Gronowicz GA, Clark SH (2005) Col1a1 promoter-targeted expression of p20 CCAAT enhancer-binding protein beta (C/EBPbeta), a truncated C/EBPbeta isoform, causes osteopenia in transgenic mice. J Biol Chem 280:8117–8124CrossRefPubMed Harrison JR, Huang YF, Wilson KA, Kelly PL, Adams DJ, Gronowicz GA, Clark SH (2005) Col1a1 promoter-targeted expression of p20 CCAAT enhancer-binding protein beta (C/EBPbeta), a truncated C/EBPbeta isoform, causes osteopenia in transgenic mice. J Biol Chem 280:8117–8124CrossRefPubMed
21.
go back to reference Insogna K, Tanaka S, Neff L, Horne W, Levy J, Baron R (1997) Role of c-Src in cellular events associated with colony-stimulating factor-1-induced spreading in osteoclasts. Mol Reprod Dev 46:104–108CrossRefPubMed Insogna K, Tanaka S, Neff L, Horne W, Levy J, Baron R (1997) Role of c-Src in cellular events associated with colony-stimulating factor-1-induced spreading in osteoclasts. Mol Reprod Dev 46:104–108CrossRefPubMed
22.
go back to reference Suda T, Jimi E, Nakamura I, Takahashi N (1997) Role of 1 alpha,25-dihydroxyvitamin D3 in osteoclast differentiation and function. Methods Enzymol 282:223–235CrossRefPubMed Suda T, Jimi E, Nakamura I, Takahashi N (1997) Role of 1 alpha,25-dihydroxyvitamin D3 in osteoclast differentiation and function. Methods Enzymol 282:223–235CrossRefPubMed
23.
go back to reference Insogna KL, Sahni M, Grey AB, Tanaka S, Horne WC, Neff L, Mitnick M, Levy JB, Baron R (1997) Colony-stimulating factor-1 induces cytoskeletal reorganization and c-src-dependent tyrosine phosphorylation of selected cellular proteins in rodent osteoclasts. J Clin Invest 100:2476–2485CrossRefPubMed Insogna KL, Sahni M, Grey AB, Tanaka S, Horne WC, Neff L, Mitnick M, Levy JB, Baron R (1997) Colony-stimulating factor-1 induces cytoskeletal reorganization and c-src-dependent tyrosine phosphorylation of selected cellular proteins in rodent osteoclasts. J Clin Invest 100:2476–2485CrossRefPubMed
24.
go back to reference Quinn J, Tam S, Sims N, Saleh H, McGregor N, Poulton I, Walker E, Scott J, Kemp B, Gillespie M (2009) Mice lacking AMP-activated kinase (AMPK) subunits β1 or β2 have low bone mass, while AICAR acts AMPK-independently to increase osteoclast formation. Bone 44:S136CrossRef Quinn J, Tam S, Sims N, Saleh H, McGregor N, Poulton I, Walker E, Scott J, Kemp B, Gillespie M (2009) Mice lacking AMP-activated kinase (AMPK) subunits β1 or β2 have low bone mass, while AICAR acts AMPK-independently to increase osteoclast formation. Bone 44:S136CrossRef
25.
go back to reference Jimi E, Shuto T, Koga T (1995) Macrophage colony-stimulating factor and interleukin-1alpha maintain the survival of osteoclast-like cells. Endocrinology 136:808–811CrossRefPubMed Jimi E, Shuto T, Koga T (1995) Macrophage colony-stimulating factor and interleukin-1alpha maintain the survival of osteoclast-like cells. Endocrinology 136:808–811CrossRefPubMed
27.
go back to reference Lee SE, Chung WJ, Kwak HB, Chung CH, Kwack KB, Lee ZH, Kim HH (2001) Tumor necrosis factor-alpha supports the survival of osteoclasts through the activation of Akt and ERK. J Biol Chem 276:49343–49349CrossRefPubMed Lee SE, Chung WJ, Kwak HB, Chung CH, Kwack KB, Lee ZH, Kim HH (2001) Tumor necrosis factor-alpha supports the survival of osteoclasts through the activation of Akt and ERK. J Biol Chem 276:49343–49349CrossRefPubMed
28.
go back to reference Miyazaki T, Katagiri H, Kanegae Y, Takayanagi H, Sawada Y, Yamamoto A, Pando MP, Asano T, Verma IM, Oda H, Nakamura K, Tanaka S (2000) Reciprocal role of ERK and NF-kappaB pathways in survival and activation of osteoclasts. J Cell Biol 148:333–342CrossRefPubMed Miyazaki T, Katagiri H, Kanegae Y, Takayanagi H, Sawada Y, Yamamoto A, Pando MP, Asano T, Verma IM, Oda H, Nakamura K, Tanaka S (2000) Reciprocal role of ERK and NF-kappaB pathways in survival and activation of osteoclasts. J Cell Biol 148:333–342CrossRefPubMed
29.
go back to reference Sakamoto K, Arnolds DE, Ekberg I, Thorell A, Goodyear LJ (2004) Exercise regulates Akt and glycogen synthase kinase-3 activities in human skeletal muscle. Biochem Biophys Res Commun 319:419–425CrossRefPubMed Sakamoto K, Arnolds DE, Ekberg I, Thorell A, Goodyear LJ (2004) Exercise regulates Akt and glycogen synthase kinase-3 activities in human skeletal muscle. Biochem Biophys Res Commun 319:419–425CrossRefPubMed
30.
go back to reference Palacio S, Felix R (2001) The role of phosphoinositide 3-kinase in spreading osteoclasts induced by colony-stimulating factor-1. Eur J Endocrinol 144:431–440CrossRefPubMed Palacio S, Felix R (2001) The role of phosphoinositide 3-kinase in spreading osteoclasts induced by colony-stimulating factor-1. Eur J Endocrinol 144:431–440CrossRefPubMed
31.
go back to reference Sugihara K, Nakatsuji N, Nakamura K, Nakao K, Hashimoto R, Otani H, Sakagami H, Kondo H, Nozawa S, Aiba A, Katsuki M (1998) Rac1 is required for the formation of three germ layers during gastrulation. Oncogene 17:3427–3433CrossRefPubMed Sugihara K, Nakatsuji N, Nakamura K, Nakao K, Hashimoto R, Otani H, Sakagami H, Kondo H, Nozawa S, Aiba A, Katsuki M (1998) Rac1 is required for the formation of three germ layers during gastrulation. Oncogene 17:3427–3433CrossRefPubMed
32.
go back to reference Gu Y, Filippi MD, Cancelas JA, Siefring JE, Williams EP, Jasti AC, Harris CE, Lee AW, Prabhakar R, Atkinson SJ, Kwiatkowski DJ, Williams DA (2003) Hematopoietic cell regulation by Rac1 and Rac2 guanosine triphosphatases. Science 302:445–449CrossRefPubMed Gu Y, Filippi MD, Cancelas JA, Siefring JE, Williams EP, Jasti AC, Harris CE, Lee AW, Prabhakar R, Atkinson SJ, Kwiatkowski DJ, Williams DA (2003) Hematopoietic cell regulation by Rac1 and Rac2 guanosine triphosphatases. Science 302:445–449CrossRefPubMed
33.
go back to reference Walmsley MJ, Ooi SK, Reynolds LF, Smith SH, Ruf S, Mathiot A, Vanes L, Williams DA, Cancro MP, Tybulewicz VL (2003) Critical roles for Rac1 and Rac2 GTPases in B cell development and signaling. Science 302:459–462CrossRefPubMed Walmsley MJ, Ooi SK, Reynolds LF, Smith SH, Ruf S, Mathiot A, Vanes L, Williams DA, Cancro MP, Tybulewicz VL (2003) Critical roles for Rac1 and Rac2 GTPases in B cell development and signaling. Science 302:459–462CrossRefPubMed
34.
go back to reference Li S, Yamauchi A, Marchal CC, Molitoris JK, Quilliam LA, Dinauer MC (2002) Chemoattractant-stimulated Rac activation in wild-type and Rac2-deficient murine neutrophils: preferential activation of Rac2 and Rac2 gene dosage effect on neutrophil functions. J Immunol 169:5043–5051PubMed Li S, Yamauchi A, Marchal CC, Molitoris JK, Quilliam LA, Dinauer MC (2002) Chemoattractant-stimulated Rac activation in wild-type and Rac2-deficient murine neutrophils: preferential activation of Rac2 and Rac2 gene dosage effect on neutrophil functions. J Immunol 169:5043–5051PubMed
35.
go back to reference Corbetta S, Gualdoni S, Albertinazzi C, Paris S, Croci L, Consalez GG, de Curtis I (2005) Generation and characterization of Rac3 knockout mice. Mol Cell Biol 25:5763–5776CrossRefPubMed Corbetta S, Gualdoni S, Albertinazzi C, Paris S, Croci L, Consalez GG, de Curtis I (2005) Generation and characterization of Rac3 knockout mice. Mol Cell Biol 25:5763–5776CrossRefPubMed
36.
go back to reference Pankov R, Endo Y, Even-Ram S, Araki M, Clark K, Cukierman E, Matsumoto K, Yamada KM (2005) A Rac switch regulates random versus directionally persistent cell migration. J Cell Biol 170:793–802CrossRefPubMed Pankov R, Endo Y, Even-Ram S, Araki M, Clark K, Cukierman E, Matsumoto K, Yamada KM (2005) A Rac switch regulates random versus directionally persistent cell migration. J Cell Biol 170:793–802CrossRefPubMed
37.
go back to reference Nakamura I, Lipfert L, Rodan GA, Le TD (2001) Convergence of αvβ3 integrin- and macrophage colony stimulating factor-mediated signals on phospholipase Cγ in prefusion osteoclasts. J Cell Biol 152:361–373CrossRefPubMed Nakamura I, Lipfert L, Rodan GA, Le TD (2001) Convergence of αvβ3 integrin- and macrophage colony stimulating factor-mediated signals on phospholipase Cγ in prefusion osteoclasts. J Cell Biol 152:361–373CrossRefPubMed
38.
go back to reference Wells CM, Walmsley M, Ooi S, Tybulewicz V, Ridley AJ (2004) Rac1-deficient macrophages exhibit defects in cell spreading and membrane ruffling but not migration. J Cell Sci 117:1259–1268CrossRefPubMed Wells CM, Walmsley M, Ooi S, Tybulewicz V, Ridley AJ (2004) Rac1-deficient macrophages exhibit defects in cell spreading and membrane ruffling but not migration. J Cell Sci 117:1259–1268CrossRefPubMed
39.
go back to reference Wheeler AP, Wells CM, Smith SD, Vega FM, Henderson RB, Tybulewicz VL, Ridley AJ (2006) Rac1 and Rac2 regulate macrophage morphology but are not essential for migration. J Cell Sci 119:2749–2757CrossRefPubMed Wheeler AP, Wells CM, Smith SD, Vega FM, Henderson RB, Tybulewicz VL, Ridley AJ (2006) Rac1 and Rac2 regulate macrophage morphology but are not essential for migration. J Cell Sci 119:2749–2757CrossRefPubMed
40.
go back to reference Pradip D, Peng X, Durden DL (2003) Rac2 specificity in macrophage integrin signaling: potential role for Syk kinase. J Biol Chem 278:41661–41669CrossRefPubMed Pradip D, Peng X, Durden DL (2003) Rac2 specificity in macrophage integrin signaling: potential role for Syk kinase. J Biol Chem 278:41661–41669CrossRefPubMed
41.
go back to reference Razzouk S, Lieberherr M, Cournot G (1999) Rac-GTPase, osteoclast cytoskeleton and bone resorption. Eur J Cell Biol 78:249–255PubMed Razzouk S, Lieberherr M, Cournot G (1999) Rac-GTPase, osteoclast cytoskeleton and bone resorption. Eur J Cell Biol 78:249–255PubMed
42.
go back to reference Boyce BF, Yoneda T, Lowe C, Soriano P, Mundy GR (1992) Requirement of pp60c-src expression for osteoclasts to form ruffled borders and resorb bone in mice. J Clin Invest 90:1622–1627CrossRefPubMed Boyce BF, Yoneda T, Lowe C, Soriano P, Mundy GR (1992) Requirement of pp60c-src expression for osteoclasts to form ruffled borders and resorb bone in mice. J Clin Invest 90:1622–1627CrossRefPubMed
43.
go back to reference Kawano T, Troiano N, Adams DJ, Wu JJ, Sun BH, Insogna K (2008) The anabolic response to parathyroid hormone is augmented in Rac2 knockout mice. Endocrinology 149:4009–4015CrossRefPubMed Kawano T, Troiano N, Adams DJ, Wu JJ, Sun BH, Insogna K (2008) The anabolic response to parathyroid hormone is augmented in Rac2 knockout mice. Endocrinology 149:4009–4015CrossRefPubMed
Metadata
Title
Osteoclasts Lacking Rac2 Have Defective Chemotaxis and Resorptive Activity
Authors
Takashi Itokowa
Mei-ling Zhu
Nancy Troiano
Jessica Bian
Tustomu Kawano
Karl Insogna
Publication date
01-01-2011
Publisher
Springer-Verlag
Published in
Calcified Tissue International / Issue 1/2011
Print ISSN: 0171-967X
Electronic ISSN: 1432-0827
DOI
https://doi.org/10.1007/s00223-010-9435-3

Other articles of this Issue 1/2011

Calcified Tissue International 1/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.